Motherhood after breast cancer: searching for la dolce vita

References

• Fredholm H, Eaker S, Frisell J et al. Breast cancer in young women: poor survival despite intensive treatment. PLoS One4(11), e7695 (2009).
   PubMed Web of Science ®Google Scholar
• Cancello G, Maisonneuve P, Rotmensz N et al. Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer. Ann. Oncol.21(10), 1974–1981 (2010).
   PubMed Web of Science ®Google Scholar
• Swanson GM, Lin CS. Survival patterns among younger women with breast cancer: the effects of age, race, stage, and treatment. J. Natl Cancer Inst. Monogr.16, 69–77 (1994).
   PubMedGoogle Scholar
• Colleoni M, Rotmensz N, Robertson C et al. Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann. Oncol.13(2), 273–279 (2002).
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Ward E et al. Cancer statistics, 2009. CA Cancer J. Clin.59(4), 225–249 (2009).
   PubMed Web of Science ®Google Scholar
• Berkowitz GS, Skovron ML, Lapinski RH, Berkowitz RL. Delayed childbearing and the outcome of pregnancy. N. Engl. J. Med.322(10), 659–664 (1990).
   PubMed Web of Science ®Google Scholar
• Partridge AH, Gelber S, Peppercorn J et al. Web-based survey of fertility issues in young women with breast cancer. J. Clin. Oncol.22(20), 4174–4183 (2004).
   PubMed Web of Science ®Google Scholar
• Peccatori FA, Azim HA Jr. Pregnancy in breast cancer survivors: a need for proper counseling. Breast (Edinb., Scotland)18(6), 337–338 (2009).
   PubMed Web of Science ®Google Scholar
• Rippy EE, Karat IF, Kissin MW. Pregnancy after breast cancer: the importance of active counselling and planning. Breast (Edinb., Scotland)18(6), 345–350 (2009).
   PubMed Web of Science ®Google Scholar
• Peccatori F, Cinieri S, Orlando L, Bellettini G. Subsequent pregnancy after breast cancer. Recent Results Cancer Res.178, 57–67 (2008).
   PubMedGoogle Scholar
• Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum. Reprod. (Oxford, Engl.)7(10), 1342–1346 (1992).
   PubMed Web of Science ®Google Scholar
• Gougeon A, Ecochard R, Thalabard JC. Age-related changes of the population of human ovarian follicles: increase in the disappearance rate of non-growing and early-growing follicles in aging women. Biol. Reproduct.50(3), 653–663 (1994).
   PubMed Web of Science ®Google Scholar
• Partridge AH, Gelber S, Peppercorn J et al. Fertility and menopausal outcomes in young breast cancer survivors. Clin. Breast Cancer8(1), 65–69 (2008).
   PubMed Web of Science ®Google Scholar
• Partridge A, Gelber S, Gelber RD et al. Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VI. Eur. J. Cancer43(11), 1646–1653 (2007).
   PubMed Web of Science ®Google Scholar
• Partridge AH, Ruddy KJ, Gelber S et al. Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer. Fertil. Steril.94(2), 638–644 (2010).
   PubMed Web of Science ®Google Scholar
• Abusief ME, Missmer SA, Ginsburg ES, Weeks JC, Partridge AH. The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer. Cancer116(4), 791–798 (2010).
   PubMed Web of Science ®Google Scholar
• Burstein HJ, Winer EP. Primary care for survivors of breast cancer. N. Engl. J. Med.343(15), 1086–1094 (2000).
   PubMed Web of Science ®Google Scholar
• Fornier MN, Modi S, Panageas KS, Norton L, Hudis C. Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane. Cancer104(8), 1575–1579 (2005).
   PubMed Web of Science ®Google Scholar
• Petrek JA, Naughton MJ, Case LD et al. Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study. J. Clin. Oncol.24(7), 1045–1051 (2006).
   PubMed Web of Science ®Google Scholar
• Berliere M, Dalenc F, Malingret N et al. Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel. BMC Cancer8, 56 (2008).
   PubMed Web of Science ®Google Scholar
• Nechuta S, Paneth N, Velie EM. Pregnancy characteristics and maternal breast cancer risk: a review of the epidemiologic literature. Cancer Causes Control21(7), 967–989 (2010).
   PubMed Web of Science ®Google Scholar
• Mustacchi P. Ramazzini and Rigoni-Stern on parity and breast cancer. Clinical impression and statistical corroboration. Arch. Int. Med.108, 639–642 (1961).
   PubMedGoogle Scholar
• Albrektsen G, Heuch I, Tretli S, Kvale G. Breast cancer incidence before age 55 in relation to parity and age at first and last births: a prospective study of one million Norwegian women. Epidemiology (Cambridge, Mass.)5(6), 604–611 (1994).
   PubMed Web of Science ®Google Scholar
• MacMahon B, Cole P, Lin TM et al. Age at first birth and breast cancer risk. Bull. World Health Organ.43(2), 209–221 (1970).
   PubMed Web of Science ®Google Scholar
• Rosner B, Colditz GA, Willett WC. Reproductive risk factors in a prospective study of breast cancer: the Nurses’ Health study. Am. J. Epidemiol.139(8), 819–835 (1994).
   PubMed Web of Science ®Google Scholar
• Albrektsen G, Heuch I, Hansen S, Kvale G. Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects. Br. J. Cancer92(1), 167–175 (2005).
   PubMed Web of Science ®Google Scholar
• Lambe M, Hsieh C, Trichopoulos D et al. Transient increase in the risk of breast cancer after giving birth. N. Engl. J. Med.331(1), 5–9 (1994).
   PubMed Web of Science ®Google Scholar
• Peterson NB, Huang Y, Newcomb PA et al. Childbearing recency and modifiers of premenopausal breast cancer risk. Cancer Epidemiol. Biomarkers Prev.17(11), 3284–3287 (2008).
   PubMed Web of Science ®Google Scholar
• Daling JR, Malone KE, Doody DR, Anderson BO, Porter PL. The relation of reproductive factors to mortality from breast cancer. Cancer Epidemiol. Biomarkers Prev.11(3), 235–241 (2002).
   PubMed Web of Science ®Google Scholar
• Bemis LT, Schedin P. Reproductive state of rat mammary gland stroma modulates human breast cancer cell migration and invasion. Cancer Res.60(13), 3414–3418 (2000).
   PubMed Web of Science ®Google Scholar
• Polyak K. Pregnancy and breast cancer: the other side of the coin. Cancer Cell9(3), 151–153 (2006).
   PubMed Web of Science ®Google Scholar
• Asztalos S, Gann PH, Hayes MK et al. Gene expression patterns in the human breast after pregnancy. Cancer Prev. Res. (Phila., PA)3(3), 301–311 (2010).
   PubMed Web of Science ®Google Scholar
• Asselin-Labat ML, Vaillant F, Sheridan JM et al. Control of mammary stem cell function by steroid hormone signalling. Nature465(7299), 798–802 (2010).
   PubMed Web of Science ®Google Scholar
• Dontu G, Abdallah WM, Foley JM et al.In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev.17(10), 1253–1270 (2003).
   PubMed Web of Science ®Google Scholar
• Dontu G, Al-Hajj M, Abdallah WM, Clarke MF, Wicha MS. Stem cells in normal breast development and breast cancer. Cell Prolif.36(Suppl. 1), 59–72 (2003).
   PubMed Web of Science ®Google Scholar
• Laban C, Bustin SA, Jenkins PJ. The GH–IGF-I axis and breast cancer. Trends Endocrinol. Metab.14(1), 28–34 (2003).
   PubMed Web of Science ®Google Scholar
• Cooper DR, Butterfield J. Pregnancy subsequent to mastectomy for cancer of the breast. Ann. Surg.171(3), 429–433 (1970).
   PubMed Web of Science ®Google Scholar
• Mignot L, Morvan F, Berdah J et al. [Pregnancy after treated breast cancer. Results of a case–control study]. Presse Med.15(39), 1961–1964 (1986).
   PubMed Web of Science ®Google Scholar
• Ariel IM, Kempner R. The prognosis of patients who become pregnant after mastectomy for breast cancer. Int. Surg.74(3), 185–187 (1989).
   PubMed Web of Science ®Google Scholar
• Sankila R, Heinavaara S, Hakulinen T. Survival of breast cancer patients after subsequent term pregnancy: ‘healthy mother effect’. Am. J. Obstet. Gynecol.170(3), 818–823 (1994).
   PubMed Web of Science ®Google Scholar
• Malamos NA, Stathopoulos GP, Keramopoulos A, Papadiamantis J, Vassilaros S. Pregnancy and offspring after the appearance of breast cancer. Oncology53(6), 471–475 (1996).
   PubMed Web of Science ®Google Scholar
• Lethaby AE, O’Neill MA, Mason BH, Holdaway IM, Harvey VJ. Overall survival from breast cancer in women pregnant or lactating at or after diagnosis. Auckland Breast Cancer Study Group. Int. J. Cancer67(6), 751–755 (1996).
   PubMed Web of Science ®Google Scholar
• Velentgas P, Daling JR, Malone KE et al. Pregnancy after breast carcinoma: outcomes and influence on mortality. Cancer85(11), 2424–2432 (1999).
   PubMed Web of Science ®Google Scholar
• Birgisson H, Tryggvadottir L, Tulinius H. [The effect of pregnancy on the survival of women diagnosed with breast cancer]. Laeknabladid86(7/8), 495–498 (2000).
   PubMedGoogle Scholar
• Gelber S, Coates AS, Goldhirsch A et al. Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer. J. Clin. Oncol.19(6), 1671–1675 (2001).
   PubMed Web of Science ®Google Scholar
• Mueller BA, Simon MS, Deapen D et al. Childbearing and survival after breast carcinoma in young women. Cancer98(6), 1131–1140 (2003).
   PubMed Web of Science ®Google Scholar
• Blakely LJ, Buzdar AU, Lozada JA et al. Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence. Cancer100(3), 465–469 (2004).
   PubMed Web of Science ®Google Scholar
• Ives A, Saunders C, Bulsara M, Semmens J. Pregnancy after breast cancer: population based study. Br. Med. J.334(7586), 194 (2007).
   PubMed Web of Science ®Google Scholar
• Kroman N, Jensen MB, Wohlfahrt J, Ejlertsen B. Pregnancy after treatment of breast cancer – a population-based study on behalf of Danish Breast Cancer Cooperative Group. Acta Oncol.47(4), 545–549 (2008).
   PubMed Web of Science ®Google Scholar
• Largillier R, Savignoni A, Gligorov J et al. Prognostic role of pregnancy occurring before or after treatment of early breast cancer patients aged <35 years: a GET(N)A Working Group analysis. Cancer115(22), 5155–5165 (2009).
   PubMed Web of Science ®Google Scholar
• Kranick JA, Schaefer C, Rowell S et al. Is pregnancy after breast cancer safe? Breast J.16(4), 404–411 (2010).
   PubMed Web of Science ®Google Scholar
• Verkooijen HM, Lim GH, Czene K et al. Effect of childbirth after treatment on long-term survival from breast cancer. Br. J. Surg.97(8), 1253–1259 (2010).
   PubMed Web of Science ®Google Scholar
• Azim HA Jr, Santoro L, Pavlidis N et al. Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies. Eur. J. Cancer47(1), 74–83 (2011).
   PubMed Web of Science ®Google Scholar
• Gorman JR, Roesch SC, Parker BA et al. Physical and mental health correlates of pregnancy following breast cancer. Psychooncology19(5), 517–524 (2010).
   PubMed Web of Science ®Google Scholar
• Pagani O, Price KN, Gelber RD et al. Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century. Breast Cancer Res. Treat.117(2), 319–324 (2009).
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet365(9472), 1687–1717 (2005).
   PubMed Web of Science ®Google Scholar
• Gerber B, Dieterich M, Muller H, Reimer T. Controversies in preservation of ovary function and fertility in patients with breast cancer. Breast Cancer Res. Treat.108(1), 1–7 (2008).
   PubMed Web of Science ®Google Scholar
• Mills JL, Simpson JL, Driscoll SG et al. Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. N. Engl. J. Med.319(25), 1617–1623 (1988).
   PubMed Web of Science ®Google Scholar
• Langagergaard V, Gislum M, Skriver MV et al. Birth outcome in women with breast cancer. Br. J. Cancer94(1), 142–146 (2006).
   PubMed Web of Science ®Google Scholar
• Dalberg K, Eriksson J, Holmberg L. Birth outcome in women with previously treated breast cancer – a population-based cohort study from Sweden. PLoS Med.3(9), e336 (2006).
   PubMed Web of Science ®Google Scholar
• Agostoni C, Trojan S, Bellu R et al. Developmental quotient at 24 months and fatty acid composition of diet in early infancy: a follow up study. Arch. Dis. Child.76(5), 421–424 (1997).
   PubMed Web of Science ®Google Scholar
• Anderson JW, Johnstone BM, Remley DT. Breast-feeding and cognitive development: a meta-analysis. Am. J. Clin. Nutr.70(4), 525–535 (1999).
   PubMed Web of Science ®Google Scholar
• Zembo CT. Breastfeeding. Obstet. Gynecol. Clin. North Am.29(1), 51–76 (2002).
   PubMed Web of Science ®Google Scholar
• Kjos SL, Henry O, Lee RM, Buchanan TA, Mishell DR Jr. The effect of lactation on glucose and lipid metabolism in women with recent gestational diabetes. Obstet. Gynecol.82(3), 451–455 (1993).
   PubMed Web of Science ®Google Scholar
• Gorman JR, Usita PM, Madlensky L, Pierce JP. A qualitative investigation of breast cancer survivors’ experiences with breastfeeding. J. Cancer Surviv.3(3), 181–191 (2009).
   PubMed Web of Science ®Google Scholar
• Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet360(9328), 187–195 (2002).
   PubMed Web of Science ®Google Scholar
• Jernstrom H, Lubinski J, Lynch HT et al. Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J. Natl Cancer Inst.96(14), 1094–1098 (2004).
   PubMed Web of Science ®Google Scholar
• McNeilly AS, Tay CC, Glasier A. Physiological mechanisms underlying lactational amenorrhea. Ann. NY Acad. Sci.709, 145–155 (1994).
   PubMed Web of Science ®Google Scholar
• Bercovich D, Goodman G. Pregnancy and lactation after breast cancer elevate plasma prolactin, do not shorten and may prolong survival. Medical Hypoth.73(6), 942–947 (2009).
   PubMed Web of Science ®Google Scholar
• Turkington RW, Underwood LE, van Wyk JJ. Elevated serum prolactin levels after pituitary-stalk section in man. N. Engl. J. Med.285(13), 707–710 (1971).
   PubMed Web of Science ®Google Scholar
• Nevalainen MT, Xie J, Torhorst J et al. Signal transducer and activator of transcription-5 activation and breast cancer prognosis. J. Clin. Oncol.22(11), 2053–2060 (2004).
   PubMed Web of Science ®Google Scholar
• Wang DY, Hampson S, Kwa HG et al. Serum prolactin levels in women with breast cancer and their relationship to survival. Eur. J. Cancer Clin. Oncol.22(4), 487–492 (1986).
   PubMedGoogle Scholar
• Tran TH, Utama FE, Lin J et al. Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism. Cancer Res.70(4), 1711–1721 (2010).
   PubMed Web of Science ®Google Scholar
• Azim HA Jr, Bellettini G, Gelber S, Peccatori FA. Breast-feeding after breast cancer: if you wish, madam. Breast Cancer Res. Treat.114(1), 7–12 (2009).
   PubMed Web of Science ®Google Scholar
• Azim HA Jr, Bellettini G, Liptrott SJ et al. Breastfeeding in breast cancer survivors: pattern, behaviour and effect on breast cancer outcome. Breast19(6), 527–531 (2010).
   PubMed Web of Science ®Google Scholar
• Helewa M, Levesque P, Provencher D et al. Breast cancer, pregnancy, and breastfeeding. J. Obstet. Gynaecol. Can.24(2), 164–180; quiz 181–164 (2002).
   PubMedGoogle Scholar
• Higgins S, Haffty BG. Pregnancy and lactation after breast-conserving therapy for early stage breast cancer. Cancer73(8), 2175–2180 (1994).
   PubMed Web of Science ®Google Scholar
• Moran MS, Colasanto JM, Haffty BG et al. Effects of breast-conserving therapy on lactation after pregnancy. Cancer J. (Sudbury, Mass.)11(5), 399–403 (2005).
   PubMed Web of Science ®Google Scholar
• Tralins AH. Lactation after conservative breast surgery combined with radiation therapy. Am. J. Clin. Oncol.18(1), 40–43 (1995).
   PubMed Web of Science ®Google Scholar
• Schnitt SJ, Goldwyn RM, Slavin SA. Mammary ducts in the areola: implications for patients undergoing reconstructive surgery of the breast. Plast. Reconstr. Surg.92(7), 1290–1293 (1993).
   PubMed Web of Science ®Google Scholar
• Camune B, Gabzdyl E. Breast-feeding after breast cancer in childbearing women. J. Perinat. Neonatal Nurs.21(3), 225–233 (2007).
   PubMed Web of Science ®Google Scholar
• Ing R, Petrakis NL, Ho JH. Unilateral breast-feeding and breast cancer. Lancet2(8029), 124–127 (1977).
   PubMed Web of Science ®Google Scholar
• Riordan J, Gill-Hopple K, Angeron J. Indicators of effective breastfeeding and estimates of breast milk intake. J. Hum. Lact.21(4), 406–412 (2005).
   PubMed Web of Science ®Google Scholar
• Anchan RM, Ginsburg ES. Fertility concerns and preservation in younger women with breast cancer. Crit. Rev. Oncol. Hematol.74(3), 175–192 (2010).
   PubMed Web of Science ®Google Scholar
• Fox KR, Scialla J, Moore H. Preventing chemotherapy-related amenorrhea using leuprolide during adjuvant chemotherapy for early-stage breast cancer. Proc. Am. Soc. Clin. Oncol.22 (2003) (Abstract 50).
   PubMed Web of Science ®Google Scholar
• Del Mastro L, Catzeddu T, Boni L et al. Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients. Ann. Oncol.17(1), 74–78 (2006).
   PubMed Web of Science ®Google Scholar
• Recchia F, Saggio G, Amiconi G et al. Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma. Cancer106(3), 514–523 (2006).
   PubMed Web of Science ®Google Scholar
• Urruticoechea A, Arnedos M, Walsh G, Dowsett M, Smith IE. Ovarian protection with goserelin during adjuvant chemotherapy for pre-menopausal women with early breast cancer (EBC). Breast Cancer Res. Treat.110(3), 411–416 (2008).
   PubMed Web of Science ®Google Scholar
• Ismail-Khan R, Minton S, Cox C et al. Preservation of ovarian function in young women treated with neoadjuvant chemotherapy for breast cancer: a randomized trial using the GnRH agonist (triptorelin) during chemotherapy. J. Clin. Oncol.26(20 Suppl.), (2008) (Abstract 524).
   Google Scholar
• Badawy A, Elnashar A, El-Ashry M, Shahat M. Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study. Fertil. Steril.91(3), 694–697 (2009).
   PubMed Web of Science ®Google Scholar
• Peccatori F, Demeestere I. GnRH analogue for chemotherapy-induced ovarian damage: too early to say? Fertil. Steril.92(2), e33; author reply e34 (2009).
   PubMed Web of Science ®Google Scholar
• Oktay K, Sonmezer M. Questioning GnRH analogs for gonadal protection in cancer patients. Fertil. Steril.92(2), e32; author reply e34 (2009).
   PubMed Web of Science ®Google Scholar
• Del Mastro L, Boni L, Michelotti A et al. Role of luteinizing hormone-releasing hormone analog (LHRHa) triptorelin (T) in preserving ovarian function during chemotherapy for early breast cancer patients: results of a multicenter Phase III trial of Gruppo Italiano Mammella (GIM) group. J. Clin. Oncol.28(15 Suppl.), (2010) (Abstract 528).
   Google Scholar
• Azem F, Amit A, Merimsky O, Lessing JB. Successful transfer of frozen–thawed embryos obtained after subtotal colectomy for colorectal cancer and before fluorouracil-based chemotherapy. Gynecologic Oncol.93(1), 263–265 (2004).
   PubMed Web of Science ®Google Scholar
• Ginsburg ES, Yanushpolsky EH, Jackson KV. In vitro fertilization for cancer patients and survivors. Fertil. Steril.75(4), 705–710 (2001).
   PubMed Web of Science ®Google Scholar
• Oktay K, Buyuk E, Davis O et al. Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum. Reprod. (Oxford, Engl.)18(1), 90–95 (2003).
   PubMed Web of Science ®Google Scholar
• Ayhan A, Salman MC, Celik H et al. Association between fertility drugs and gynecologic cancers, breast cancer, and childhood cancers. Acta Obstet. Gynecol. Scand. Suppl.83(12), 1104–1111 (2004).
   Google Scholar
• Omland AK, Fedorcsak P, Storeng R et al. Natural cycle IVF in unexplained, endometriosis-associated and tubal factor infertility. Hum. Reprod. (Oxford, Engl.)16(12), 2587–2592 (2001).
   PubMed Web of Science ®Google Scholar
• Oktay K. Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation. J. Clin. Oncol.23(16), 3858–3859 (2005).
   PubMed Web of Science ®Google Scholar
• Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J. Clin. Oncol.23(19), 4347–4353 (2005).
   PubMed Web of Science ®Google Scholar
• Oktay K, Hourvitz A, Sahin G et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J. Clin. Endocrinol. Metab.91(10), 3885–3890 (2006).
   PubMed Web of Science ®Google Scholar
• Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J. Clin. Oncol.26(16), 2630–2635 (2008).
   PubMed Web of Science ®Google Scholar
• Lee SJ, Schover LR, Partridge AH et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J. Clin. Oncol.24(18), 2917–2931 (2006).
   PubMed Web of Science ®Google Scholar